Dynasil Announces Linda Zuckerman, Ph.D. as New CEO of Xcede Technologies, Inc.

NEWTON, Mass., Sept. 15, 2015 /PRNewswire/ — Dynasil Corporation of America (NASDAQ: DYSL) today announced the appointment of Linda Zuckerman, Ph.D. as CEO of Xcede Technologies, Inc., Dynasil’s majority owned subsidiary.

Dr. Zuckerman brings to Xcede more than 15 years of biotechnology experience in developing biologics, pharmaceuticals and medical devices from discovery to licensure in both the EU and US. Her expertise and leadership in both early and late stage product development resulted in several US and EU approvals for topical hemostats such as RECOTHROM® and Raplixa® and related medical devices.

Click here to read more.